C.T. Fitzpatrick - Vulcan Value Partners,
Holding/activity history for CVS Health Corp. (CVS)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2021 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2021 Q1 | 8,751 | <0.01 | Reduce 99.73% | 1.43 | $75.19 | $658,000 | SEC |
| 2020 Q4 | 3,230,345 | 1.43 | Add 5.85% | 0.08 | $68.30 | $220,633,000 | SEC |
| 2020 Q3 | 3,051,845 | 1.39 | Reduce 30.39% | 0.68 | $58.40 | $178,228,000 | SEC |
| 2020 Q2 | 4,384,010 | 2.24 | Reduce 17.42% | 0.57 | $64.97 | $284,829,000 | SEC |
| 2020 Q1 | 5,308,715 | 3.26 | Reduce 20.55% | 0.79 | $59.33 | $314,966,000 | SEC |
| 2019 Q4 | 6,681,892 | 3.83 | Reduce 23.68% | 1.11 | $74.29 | $496,398,000 | SEC |
| 2019 Q3 | 8,754,912 | 4.67 | Reduce 1.92% | 0.08 | $63.07 | $552,172,000 | SEC |
| 2019 Q2 | 8,926,631 | 4.32 | Add 12.17% | 0.47 | $54.49 | $486,412,000 | SEC |
| 2019 Q1 | 7,958,469 | 3.70 | Add 56.77% | 1.34 | $53.93 | $429,200,000 | SEC |
| 2018 Q4 | 5,076,516 | 3.07 | Reduce 12.64% | 0.42 | $65.52 | $332,613,000 | SEC |
| 2018 Q3 | 5,811,079 | 3.34 | Reduce 38.98% | 1.91 | $78.72 | $457,448,000 | SEC |
| 2018 Q2 | 9,522,744 | 4.90 | Add 2.34% | 0.11 | $64.35 | $612,789,000 | SEC |
| 2018 Q1 | 9,305,338 | 4.68 | Add 5.27% | 0.23 | $62.21 | $578,885,000 | SEC |
| 2017 Q4 | 8,839,878 | 5.32 | Add 1.19% | 0.06 | $72.50 | $640,892,000 | SEC |
| 2017 Q3 | 8,736,102 | 6.25 | Add 13.61% | 0.75 | $81.32 | $710,419,000 | SEC |
| 2017 Q2 | 7,689,383 | 5.67 | Add 1.36% | 0.08 | $80.46 | $618,688,000 | SEC |
| 2017 Q1 | 7,586,549 | 5.29 | Add 42.22% | 1.57 | $78.50 | $595,545,000 | SEC |
| 2016 Q4 | 5,334,307 | 3.87 | Buy | 3.87 | $78.91 | $420,930,000 | SEC |
| 2016 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2015 Q4 | 2,150 | <0.01 | Buy | <0.01 | $97.67 | $210,000 | SEC |
| 2014 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2014 Q2 | 475 | <0.01 | Buy | <0.01 | $75.79 | $36,000 | SEC |